anti-PD-L1 antibody-immune modulator conjugate (LegoChem Biosciences)

N/A

Report date: 2025/06/11 10:35:13

Base Information

Drug Nameanti-PD-L1 antibody-immune modulator conjugate (LegoChem Biosciences)

Drug Alias Namedual PD-L1 checkpoint inhibitor/STING agonist (LegoChem Biosciences)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionStimulator of interferon genes stimulantsProgrammed death-ligand 1 blockersDendritic cells stimulants +[5]

TargetsProgrammed death-ligand 1Stimulator of interferon genes

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLigaChem Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesLigaChem Biosciences Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A